Scientists probe brain synapses to unlock secrets of mental illness
NCT ID NCT07234851
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at brain tissue and lab-grown nerve cells from people with schizophrenia, depression, bipolar disorder, frontotemporal dementia, and Alzheimer's. Researchers want to find out how problems with synapses—the connections between brain cells—differ in these conditions. The goal is to better understand what goes wrong in the brain, which could guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal new targets for future treatments for several mental and neurodegenerative disorders.
- What could go wrong
- This is an observational study using stored tissue and cells, not a treatment trial. Findings may not directly lead to therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Institute Sant Pau
Barcelona, 08025, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your brain help unlock Alzheimer's secrets?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Can a new drug tame Alzheimer's? early trial aims to find out
- A scan that sees Alzheimer's tangles? trial puts tau tracer to the test
- Can couples counseling lift depression in women?
- Brain wave clues: could inflammation markers forecast ECT outcomes?